Ameritas Investment Partners, Inc. Ngm Biopharmaceuticals Inc Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $7,780 - $10,920	618 Added 24.73%	3,117 $40,000
Q3 2021 Nov 15, 2021	BUY	$20.15 - $26.19 $8,059 - $10,476	400 Added 19.06%	2,499 $53,000
Q4 2019 Feb 13, 2020	BUY	$9.97 - $20.28 $15,014 - $30,541	1,506 Added 253.96%	2,099 $39,000
Q2 2019 Aug 14, 2019	BUY	$12.56 - $16.6 $7,448 - $9,843	593 New	593 $9,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.